Sage Therapeutics, Inc.

Q2 2021 13F Holders

Symbol
SAGE
CUSIP
78667J108
Type
Equity
Class
COM
Num filers
265
Total reported value, excl. options
$2.88B
Manager Report Date Value ($000) Shares